AB-1002
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for AB-1002, covering 2025-04-08 to 2025-04-08. Get the full timeline:
Most recent: Clinical Trial Update: AB-1002 in Patients With Class III Heart Failure [Phase 1]